Biohaven BHVN
NYSE BHVN
$15.66 -0.20 (-1.26%)
As of: Sep 4, 2026 · 1:37 PM EDT

Biohaven (BHVN) Non Operating Income (2021 - 2026)

Biohaven (BHVN) posted Non Operating Income of $168000.0 for Q1 2026, up 106.8% sequentially from -$2.5 million in Q4 2025, and down 65.92% YoY from $493000.0 in Q1 2025.

Analysis

Biohaven (BHVN) Non Operating Income (2021 - 2026) Analysis & Trends

Biohaven has reported Non Operating Income for 6 years, with the latest figure at $168000.0 in Q1 2026.

  • Quarterly Non Operating Income fell 65.92% year-over-year to $168000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (down 78.45% YoY) and the FY2025 annual result came in at $8.0 million, down 79.71% from the prior year.
  • Non Operating Income rose to $168000.0 in Q1 2026 per BHVN's latest filing, from -$2.5 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $17.8 million in Q3 2024 and troughed at -$3.8 million in Q3 2025.
  • A 5-year average of $4.5 million and a median of $3.7 million in 2024 frame the typical range for Non Operating Income.
  • The sharpest annual moves came in 2022 and 2023: Non Operating Income sank 226.41% in 2022, then surged 205825.0% in 2023.
  • Over 5 years, Non Operating Income stood at -$1.8 million in 2022, then surged by 521.27% to $7.7 million in 2023, then sank by 59.5% to $3.1 million in 2024, then sank by 178.76% to -$2.5 million in 2025, then surged by 106.8% to $168000.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $168000.0, -$2.5 million, and -$3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -139.24 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -51.63 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Biohaven 2.35 Bn 2.09 Bn - -12.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.02 Mn
Mar 31, 2026 168,000.00
Dec 31, 2025 -2.47 Mn
Sep 30, 2025 -3.84 Mn
Jun 30, 2025 13.82 Mn
Mar 31, 2025 493,000.00
Dec 31, 2024 3.14 Mn
Sep 30, 2024 17.81 Mn
Jun 30, 2024 14.18 Mn
Mar 31, 2024 4.31 Mn
Dec 31, 2023 7.74 Mn
Sep 30, 2023 4.69 Mn
Jun 30, 2023 5.84 Mn
Mar 31, 2023 8.23 Mn
Dec 31, 2022 -1.84 Mn
Jun 30, 2022 -67,000.00
Mar 31, 2022 -4,000.00
Dec 31, 2021 1.45 Mn
Sep 30, 2021 -5,000.00